Advancements in the Treatment of Desmoid Tumors : Episode 10
Targeting NOTCH Pathway Signaling with Nirogacestat
Mark Agulnik, MD, examines the mechanism of action of nirogacestat, emphasizing the impact of ϒ-secretase inhibition on NOTCH pathway signaling.
EP: 1.An Overview of the Landscape Surrounding Desmoid Tumors
EP: 2.Expert Perspectives on the Pathogenesis and Diagnosis of Desmoid Tumors
EP: 3.Signs and Symptoms of Desmoid Tumors and Their Impact on Quality of Life
EP: 4.Active Surveillance in Frontline Management of Desmoid Tumors
EP: 5.The Evolving Role of Surgery in the Management of Desmoid Tumors
EP: 6.Treatment Strategies Using Radiotherapy or Other Locoregional Approaches in Desmoid Tumors
EP: 7.Approaches to Systemic Therapy in Desmoid Tumors: The Role of Chemotherapy
EP: 8.The Role of Supportive Care Measures in Patients with Desmoid Tumors
EP: 9.Desmoid Tumors in Women: Special Considerations for Pregnancy and Contraception
Now Viewing
EP: 10.Targeting NOTCH Pathway Signaling with Nirogacestat
EP: 11.DeFi: Nirogacestat in Patients with Progressing Desmoid Tumors
EP: 12.Impact of Nirogacestat on Pain, Quality of Life, and Fertility in Patients with Desmoid Tumors
EP: 13.Nirogacestat's Impact on the Future Treatment of Desmoid Tumors
EP: 14.Future Perspectives on the Treatment of Desmoid Tumors
Related Videos
